Ractigen, Author at Ractigen Therapeutics

Presentations

Event: American Diabetes Association (ADA)-2026 Scientific Sessions(New Orleans, USA) View Poster View News: Ractigen Therapeutics…

Ractigen06/07/2026

Company News News Highlight

Breakthrough preclinical data demonstrate that LiCO-saUcp1 effectively turns white fat into calorie-burning brown fat, driving…

Ractigen06/06/2026

Company News News Highlight RAG-17

— Single intrathecal dose of SCAD-siRNA therapeutic RAG-17 yields favorable safety profile and profound, durable…

Ractigen04/21/2026

Presentations Uncategorized

Event: 2026 American Academy of Neurology (AAN) Annual Meeting（Chicago） View Poster View News: Ractigen Therapeutics…

Ractigen04/19/2026

Company News News Highlight RAG-01

Nantong, China – March 19, 2026 – Ractigen Therapeutics, a pioneering clinical-stage biotechnology company developing innovative small…

Ractigen03/19/2026

Nantong, China – January 13, 2026 – Ractigen Therapeutics is pleased to announce that the…

Ractigen01/13/2026

Homepage News News Highlight

NANTONG, China, December 12, 2025 – Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA)…

Ractigen12/12/2025

Homepage News News Highlight

SUZHOU, China, November 17, 2025 – Ractigen Therapeutics, a clinical-stage biotechnology company, today announced the publication…

Ractigen11/17/2025

Ractigen